Skip to content

LABOVET: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LABOVET

BE 0840.594.080
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€824
2024 · -€654+€1,478
Equity
€6,286
2024 · €5,462+€824
Cash
€7,901
2024 · €8,403-€501
Balance sheet total
€13,925
2024 · €14,192-€266

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€2,848

    up €2,848 (+117.2%), from €2,430 to €5,278

    of which Trade receivables: +€1,641

  • Tangible fixed assets -€2,563

    no longer reported in 2025 (was €2,563)

  • Cash -€501

    down €501 (-6.0%), from €8,403 to €7,901

    mainly Receivables within one year (-€2,848) and Current portion of long-term debt (-€1,768)

Equity and liabilities
  • Current portion of long-term debt -€1,768

    no longer reported in 2025 (was €1,768)

  • Trade debts +€1,763

    up €1,763 (+130.6%), from €1,349 to €3,112

  • Tax, wage and social debts -€1,275

    down €1,275 (-31.1%), from €4,096 to €2,821

  • Profit (loss) carried forward +€824

    up €824 (+21.5%), from -€3,838 to -€3,014

  • Other debts +€189

    up €189 (+12.5%), from €1,517 to €1,706

Income statement
  • Depreciation -€1,282

    down €1,282 (-33.3%), from €3,845 to €2,563

  • Gross operating margin +€606

    up €606 (+12.8%), from €4,719 to €5,325

  • Taxes +€404

    up €404 (+34.7%), from €1,163 to €1,567

  • Other operating charges +€79

    new in 2025: €79

  • Financial charges -€72

    down €72 (-19.8%), from €365 to €292

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€654
Gross operating margin +€606
Depreciation +€1,282
Other operating charges -€79
Financial charges +€72
Taxes -€404
Result 2025 €824

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1,266
Investment €0
Financing -€1,768
Cash 2024 €8,403
Net result for the year +€824
Depreciation +€2,563
Receivables within one year -€2,848
Deferred charges and accrued income +€49
Trade debts +€1,763
Tax, wage and social debts -€1,275
Other debts +€189
Current portion of long-term debt -€1,768
Cash 2025 €7,901
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €14,192 €13,925 -€266 -1.9%
Fixed assets 21/28 €2,563 - -€2,563
Tangible fixed assets 22/27 €2,563 - -€2,563
Furniture and vehicles 24 €2,563 - -€2,563
Current assets 29/58 €11,628 €13,925 +€2,297 +19.8%
Amounts receivable within one year 40/41 €2,430 €5,278 +€2,848 +117.2%
Trade receivables 40 €2,430 €4,071 +€1,641 +67.5%
Other amounts receivable 41 - €1,207 +€1,207
Cash at bank and in hand 54/58 €8,403 €7,901 -€501 -6.0%
Deferred charges and accrued income 490/1 €795 €746 -€49 -6.2%
Total equity and liabilities 10/49 €14,192 €13,925 -€266 -1.9%
Equity 10/15 €5,462 €6,286 +€824 +15.1%
Contributions 10/11 €7,440 €7,440 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 -€3,838 -€3,014 +€824 +21.5%
Amounts payable 17/49 €8,730 €7,639 -€1,091 -12.5%
Amounts payable within one year 42/48 €8,730 €7,639 -€1,091 -12.5%
Current portion of amounts payable after more than one year 42 €1,768 - -€1,768
Trade debts 44 €1,349 €3,112 +€1,763 +130.6%
Suppliers 440/4 €1,349 €3,112 +€1,763 +130.6%
Taxes, remuneration and social security 45 €4,096 €2,821 -€1,275 -31.1%
Taxes 450/3 €4,096 €2,821 -€1,275 -31.1%
Other amounts payable 47/48 €1,517 €1,706 +€189 +12.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,845 €2,563 -€1,282 -33.3%
Other operating charges 640/8 - €79 +€79
Gross operating margin 9900 €4,719 €5,325 +€606 +12.8%
Operating profit (loss) 9901 €874 €2,683 +€1,809 +207.0%
Financial charges 65/66B €365 €292 -€72 -19.8%
Recurring financial charges 65 €365 €292 -€72 -19.8%
Profit (loss) for the period before taxes 9903 €510 €2,391 +€1,881 +369.3%
Income taxes 67/77 €1,163 €1,567 +€404 +34.7%
Profit (loss) for the period 9904 -€654 €824 +€1,478
Profit (loss) for the period to be appropriated 9905 -€654 €824 +€1,478

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.